Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease

Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart and vessels 2021-03, Vol.36 (3), p.315-320
Hauptverfasser: Deguchi, Yuki, Saito, Yuichi, Nakao, Motohiro, Shiraishi, Hirokazu, Sakamoto, Naoya, Kobayashi, Satoru, Kobayashi, Yoshio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 320
container_issue 3
container_start_page 315
container_title Heart and vessels
container_volume 36
creator Deguchi, Yuki
Saito, Yuichi
Nakao, Motohiro
Shiraishi, Hirokazu
Sakamoto, Naoya
Kobayashi, Satoru
Kobayashi, Yoshio
description Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by − 2.3 ml/min/1.73 m 2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.
doi_str_mv 10.1007/s00380-020-01701-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32930865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2442845630</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-19203e41c90653b14c60034f7a2f0b7eade2f5e13f09d510f7a6efab505955c23</originalsourceid><addsrcrecordid>eNqNkc-KFDEQxoMo7rj6Ah4k4EWQ1krSSXeOMvgPFrys5yadrrgZe5IxSbvMS_jMZrbXXfAgHkIS6vcVVd9HyHMGbxhA9zYDiB4a4PWwDljDHpANU0w2XHbiIdmAZtD0gndn5EnOOwAmNdOPyZngWkCv5Ib8ukxmh7bEdKTR0YTBzNQtwRYfA7VXJnxDasJEv_sp4JH6sFsqalzBRA-Y7FJMwLhkamOKwaQTUms_Mdx08IEeTPH1l-m1L1c0FzPOeE-bVOkjnXxGk_EpeeTMnPHZ7X1Ovn54f7n91Fx8-fh5--6isULr0jDNQWDLrAYlxchaq6oXresMdzB2aCbkTiITDvQkGdSCQmdGCVJLabk4J6_WvocUfyyYy7D32eI8r8sMvG1530oloKIv_0J3cUnVphPVd7pTHFSl-ErZFHNO6IZD8vu64MBgOKU1rGkNNa3hJq2BVdGL29bLuMfpTvInngr0K3CNY3TZVh8t3mEAIJXWquX1BWzrizl5vo1LKFX6-v-llRYrnStRI0_3S_5j_t_k-8Ml</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487976206</pqid></control><display><type>article</type><title>Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease</title><source>SpringerNature Journals</source><creator>Deguchi, Yuki ; Saito, Yuichi ; Nakao, Motohiro ; Shiraishi, Hirokazu ; Sakamoto, Naoya ; Kobayashi, Satoru ; Kobayashi, Yoshio</creator><creatorcontrib>Deguchi, Yuki ; Saito, Yuichi ; Nakao, Motohiro ; Shiraishi, Hirokazu ; Sakamoto, Naoya ; Kobayashi, Satoru ; Kobayashi, Yoshio</creatorcontrib><description>Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by − 2.3 ml/min/1.73 m 2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-020-01701-1</identifier><identifier>PMID: 32930865</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Angioplasty ; Biomedical Engineering and Bioengineering ; Cardiac &amp; Cardiovascular Systems ; Cardiac Surgery ; Cardiology ; Cardiovascular disease ; Cardiovascular System &amp; Cardiology ; Cerebral infarction ; Coronary artery ; Coronary artery disease ; Coronary vessels ; Creatinine ; Epidermal growth factor receptors ; Glomerular filtration rate ; Heart diseases ; Injuries ; Kidneys ; Life Sciences &amp; Biomedicine ; Medicine ; Medicine &amp; Public Health ; Myocardial infarction ; Original Article ; Peripheral Vascular Disease ; Renal function ; Science &amp; Technology ; Vascular Surgery</subject><ispartof>Heart and vessels, 2021-03, Vol.36 (3), p.315-320</ispartof><rights>Springer Japan KK, part of Springer Nature 2020</rights><rights>Springer Japan KK, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>3</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000569964200001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c399t-19203e41c90653b14c60034f7a2f0b7eade2f5e13f09d510f7a6efab505955c23</citedby><cites>FETCH-LOGICAL-c399t-19203e41c90653b14c60034f7a2f0b7eade2f5e13f09d510f7a6efab505955c23</cites><orcidid>0000-0003-3574-0685</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00380-020-01701-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00380-020-01701-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27928,27929,41492,42561,51323</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32930865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deguchi, Yuki</creatorcontrib><creatorcontrib>Saito, Yuichi</creatorcontrib><creatorcontrib>Nakao, Motohiro</creatorcontrib><creatorcontrib>Shiraishi, Hirokazu</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Kobayashi, Satoru</creatorcontrib><creatorcontrib>Kobayashi, Yoshio</creatorcontrib><title>Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>HEART VESSELS</addtitle><addtitle>Heart Vessels</addtitle><description>Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by − 2.3 ml/min/1.73 m 2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.</description><subject>Angioplasty</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Cardiac &amp; Cardiovascular Systems</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular System &amp; Cardiology</subject><subject>Cerebral infarction</subject><subject>Coronary artery</subject><subject>Coronary artery disease</subject><subject>Coronary vessels</subject><subject>Creatinine</subject><subject>Epidermal growth factor receptors</subject><subject>Glomerular filtration rate</subject><subject>Heart diseases</subject><subject>Injuries</subject><subject>Kidneys</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Myocardial infarction</subject><subject>Original Article</subject><subject>Peripheral Vascular Disease</subject><subject>Renal function</subject><subject>Science &amp; Technology</subject><subject>Vascular Surgery</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><recordid>eNqNkc-KFDEQxoMo7rj6Ah4k4EWQ1krSSXeOMvgPFrys5yadrrgZe5IxSbvMS_jMZrbXXfAgHkIS6vcVVd9HyHMGbxhA9zYDiB4a4PWwDljDHpANU0w2XHbiIdmAZtD0gndn5EnOOwAmNdOPyZngWkCv5Ib8ukxmh7bEdKTR0YTBzNQtwRYfA7VXJnxDasJEv_sp4JH6sFsqalzBRA-Y7FJMwLhkamOKwaQTUms_Mdx08IEeTPH1l-m1L1c0FzPOeE-bVOkjnXxGk_EpeeTMnPHZ7X1Ovn54f7n91Fx8-fh5--6isULr0jDNQWDLrAYlxchaq6oXresMdzB2aCbkTiITDvQkGdSCQmdGCVJLabk4J6_WvocUfyyYy7D32eI8r8sMvG1530oloKIv_0J3cUnVphPVd7pTHFSl-ErZFHNO6IZD8vu64MBgOKU1rGkNNa3hJq2BVdGL29bLuMfpTvInngr0K3CNY3TZVh8t3mEAIJXWquX1BWzrizl5vo1LKFX6-v-llRYrnStRI0_3S_5j_t_k-8Ml</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Deguchi, Yuki</creator><creator>Saito, Yuichi</creator><creator>Nakao, Motohiro</creator><creator>Shiraishi, Hirokazu</creator><creator>Sakamoto, Naoya</creator><creator>Kobayashi, Satoru</creator><creator>Kobayashi, Yoshio</creator><general>Springer Japan</general><general>Springer Nature</general><general>Springer Nature B.V</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3574-0685</orcidid></search><sort><creationdate>20210301</creationdate><title>Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease</title><author>Deguchi, Yuki ; Saito, Yuichi ; Nakao, Motohiro ; Shiraishi, Hirokazu ; Sakamoto, Naoya ; Kobayashi, Satoru ; Kobayashi, Yoshio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-19203e41c90653b14c60034f7a2f0b7eade2f5e13f09d510f7a6efab505955c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angioplasty</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Cardiac &amp; Cardiovascular Systems</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular System &amp; Cardiology</topic><topic>Cerebral infarction</topic><topic>Coronary artery</topic><topic>Coronary artery disease</topic><topic>Coronary vessels</topic><topic>Creatinine</topic><topic>Epidermal growth factor receptors</topic><topic>Glomerular filtration rate</topic><topic>Heart diseases</topic><topic>Injuries</topic><topic>Kidneys</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Myocardial infarction</topic><topic>Original Article</topic><topic>Peripheral Vascular Disease</topic><topic>Renal function</topic><topic>Science &amp; Technology</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deguchi, Yuki</creatorcontrib><creatorcontrib>Saito, Yuichi</creatorcontrib><creatorcontrib>Nakao, Motohiro</creatorcontrib><creatorcontrib>Shiraishi, Hirokazu</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Kobayashi, Satoru</creatorcontrib><creatorcontrib>Kobayashi, Yoshio</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deguchi, Yuki</au><au>Saito, Yuichi</au><au>Nakao, Motohiro</au><au>Shiraishi, Hirokazu</au><au>Sakamoto, Naoya</au><au>Kobayashi, Satoru</au><au>Kobayashi, Yoshio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><stitle>HEART VESSELS</stitle><addtitle>Heart Vessels</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>36</volume><issue>3</issue><spage>315</spage><epage>320</epage><pages>315-320</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>Acute kidney injury usually assessed within 48 h after percutaneous coronary intervention (PCI) is associated with poor clinical outcomes, and persistent kidney damage is also strongly related to long-term mortality. However, little is known about longitudinal renal function change from a very early period to long-term follow-up after PCI. A total of 327 patients with stable coronary artery disease underwent elective PCI. Renal function was assessed with serum creatinine levels and estimated glomerular filtration rate (eGFR) at baseline, 1 day after PCI, at 1 year and at the latest follow-up. Kidney injury was defined as an increase in creatinine levels ≥ 0.3 mg/dl or ≥ 50% from baseline at each timepoint. Major adverse cardiovascular events (MACE) was defined as a composite of death, myocardial infarction, and stroke. eGFR was significantly increased 1 day after PCI, while it was progressively decreased at 1-year and long-term follow-up (median 28 months). Overall, eGFR was declined by − 2.3 ml/min/1.73 m 2 per year. Only one (0.3%) patient developed kidney injury 1 day after PCI, whereas kidney injury at 1-year and long-term follow-up was observed in 15 (4.6%) and 27 (8.3%). During the follow-up period, 23 (7.0%) patients had MACE. The incidence of subsequent MACE was significantly higher in patients with kidney injury at 1 year than those without. In conclusion, kidney injury within 24 h after elective PCI was rarely observed. eGFR was progressively decreased over time, and mid-term kidney injury at 1 year was associated with future MACE.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>32930865</pmid><doi>10.1007/s00380-020-01701-1</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3574-0685</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0910-8327
ispartof Heart and vessels, 2021-03, Vol.36 (3), p.315-320
issn 0910-8327
1615-2573
language eng
recordid cdi_pubmed_primary_32930865
source SpringerNature Journals
subjects Angioplasty
Biomedical Engineering and Bioengineering
Cardiac & Cardiovascular Systems
Cardiac Surgery
Cardiology
Cardiovascular disease
Cardiovascular System & Cardiology
Cerebral infarction
Coronary artery
Coronary artery disease
Coronary vessels
Creatinine
Epidermal growth factor receptors
Glomerular filtration rate
Heart diseases
Injuries
Kidneys
Life Sciences & Biomedicine
Medicine
Medicine & Public Health
Myocardial infarction
Original Article
Peripheral Vascular Disease
Renal function
Science & Technology
Vascular Surgery
title Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T23%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trajectory%20of%20renal%20function%20change%20and%20kidney%20injury%20after%20percutaneous%20coronary%20intervention%20in%20patients%20with%20stable%20coronary%20artery%20disease&rft.jtitle=Heart%20and%20vessels&rft.au=Deguchi,%20Yuki&rft.date=2021-03-01&rft.volume=36&rft.issue=3&rft.spage=315&rft.epage=320&rft.pages=315-320&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-020-01701-1&rft_dat=%3Cproquest_pubme%3E2442845630%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487976206&rft_id=info:pmid/32930865&rfr_iscdi=true